Study to provide Sorafenib to Patients with Advanced Renal Cell Carcinoma in Expanded Access Program
|Effective start/end date||10/6/05 → 12/31/10|
- BAYER CORP
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.